FDA recall D-929-2015

Attix Pharmaceuticals · Class II · drug

Product

Ticarcillin Sodium/Potassium Clavulanate (30:1) active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

Reason for recall

Stability Data Does Not Support Expiry: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged without data to support the printed expiry date.

Distribution

Nationwide to compounding pharmacies and research organizations.

Key facts

Status
Terminated
Initiation date
2014-11-14
Report date
2015-04-29
Termination date
2015-10-07
Voluntary/Mandated
Voluntary: Firm initiated
Location
Toronto, Canada

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-929-2015